Alberta Investment Management Corp Pfizer Inc Transaction History

Alberta Investment Management Corp

$13.3 Billion
Q4 2024

A detailed history of Alberta Investment Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, Alberta Investment Management Corp holds 28,160 shares of PFE stock, worth $738,073. This represents 0.01% of its overall portfolio holdings.

Number of Shares

28,160

Previous 588,157 95.21%

Holding current value

$738,073

Previous $17 Million 95.61%

% of portfolio

0.01%

Previous 0.17%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$24.8 - $30.19 $13.9 Million - $16.9 Million	-559,997 Reduced 95.21%	28,160 $747,000
Q3 2024 Nov 05, 2024	BUY	$27.7 - $31.39 $16.3 Million - $18.5 Million	588,157 New	588,157 $17 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $833,010 - $956,562	-32,175 Reduced 17.26%	154,200 $4.28 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $840,732 - $1.09 Million	32,175 Added 20.87%	186,375 $5.37 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $468,385 - $547,495	-14,596 Reduced 8.65%	154,200 $5.11 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $9.76 Million - $12.7 Million	-247,664 Reduced 59.47%	168,796 $6.89 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $25.7 Million - $33.5 Million	-614,723 Reduced 59.61%	416,460 $21.3 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.53 Million - $1.87 Million	-35,000 Reduced 3.28%	1,031,183 $45.1 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $7.49 Million - $8.89 Million	-161,073 Reduced 13.12%	1,066,183 $55.9 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $9.87 Million - $12.2 Million	215,800 Added 21.34%	1,227,256 $63.5 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $4.64 Million - $6.88 Million	112,325 Added 12.49%	1,011,456 $59.7 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $8.75 Million - $11.2 Million	222,931 Added 32.97%	899,131 $38.7 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $3.13 Million - $3.55 Million	-87,200 Reduced 11.42%	676,200 $26.5 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $8.23 Million - $9.28 Million	245,800 Added 47.49%	763,400 $27.7 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $13 Million - $16.5 Million	-387,800 Reduced 42.83%	517,600 $19.1 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $866,775 - $1.02 Million	-27,300 Reduced 2.93%	905,400 $33.2 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $4.9 Million - $5.94 Million	162,600 Added 21.11%	932,700 $30.5 Million
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $5.06 Million - $7.23 Million	-187,300 Reduced 19.56%	770,100 $25.1 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $31 Million - $35.2 Million	942,300 Added 6240.4%	957,400 $37.5 Million
Q3 2019 Oct 23, 2019	SELL	$32.49 - $42.13 $1.02 Million - $1.32 Million	-31,300 Reduced 67.46%	15,100 $543,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $18,490 - $20,760	-500 Reduced 1.07%	46,400 $2.01 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $952,500 - $1.05 Million	25,400 Added 118.14%	46,900 $1.99 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $261,596 - $298,248	-6,800 Reduced 24.03%	21,500 $938,000
Q3 2018 Nov 16, 2018	SELL	$34.47 - $41.81 $17.5 Million - $21.2 Million	-507,000 Reduced 94.71%	28,300 $1.25 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $465,017 - $495,755	-14,100 Reduced 2.57%	535,300 $19.4 Million
Q1 2018 May 16, 2018	BUY	$31.91 - $37.02 $14.4 Million - $16.7 Million	450,100 Added 453.27%	549,400 $19.5 Million
Q4 2017 Feb 15, 2018	SELL	$33.26 - $35.29 $20 Million - $21.2 Million	-600,000 Reduced 85.8%	99,300 $3.6 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $21.7 Million - $23.9 Million	699,300	699,300 $25 Million

Others Institutions Holding PFE

# of Institutions

3,377

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account

Alberta Investment Management Corp Pfizer Inc Transaction History